Advertisement

Reactions Weekly

, Volume 1753, Issue 1, pp 196–196 | Cite as

Infliximab

Infusion reaction and delayed hypersensitivity reaction: 3 case reports
Case report
  • 3 Downloads

Reference

  1. Yoshimura N, et al. Development of a C1q-immobilized (Cim) assay to measure total antibodies to infliximab and its clinical relevance in patients with inflammatory bowel disease. Cytokine 120: 54-61, Aug 2019. Available from: URL: http://doi.org/10.1016/j.cyto.2019.02.014 - Japan

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations